The DOI matches its Crossref record; the references it cites are not checked yet.
Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
Open accessAbstract
A clear relationship between diabetes and cardiovascular disease has been established for decades. Despite this, the mechanisms by which diabetes contributes to plaque formation remain in question. Some of this confusion derives from studies in type 2 diabetics where multiple components of metabolic syndrome show proatherosclerotic effects independent of underlying diabetes. However, the hyperglycemia that defines the diabetic condition independently affects atherogenesis in cell culture systems, animal models, and human patients. Endothelial cell biology plays a central role in atherosclerotic plaque formation regulating vessel permeability, inflammation, and thrombosis. The current paper highlights the mechanisms by which hyperglycemia affects endothelial cell biology to promote plaque formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperglycaemia also promotes atherosclerosis.233”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [233]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 280 · Cited by 176
Research works printed but not linked: 10
- 2006, Handbook of Experimental Pharmacology, 135
- 1991, American Journal of Hypertension, 4, 260
- 1987, New England Journal of Medicine, 317, 836
- 1998, Cellular and Molecular Biology (Noisy-le-Grand), 44, 1139
- 2001, Diabetes and Metabolism, 27, 535
- 2008, Zhonghua Fu Chan Ke Za Zhi, 43, 746
- 2007, Behavioral Healthcare, 27, 22
- 2011, Journal of Endocrinological Investigation, 34, e343
- 1994, Research Communications in Chemical Pathology and Pharmacology, 84, 93
- 1993, American Journal of Physiology, 265, E783
Metadata
- Authors
- Funk, S. D., Yurdagul, A., & Orr, A. W.
- Affiliations
- Louisiana State University Health Sciences Center Shreveport (US)
- Corresponding author
- Orr, A. Wayne
- Venue
- International Journal of Vascular Medicine
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-19
- ISSN
- 2090-2824 (ISSN-L)
- 2090-2832
- PMC
- PMC3303762
- OpenAlex
- W1969615558
- Cited by
- 176
- References
- 280
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 11 · 2023: 9 · 2022: 10 · 2021: 18 · 2020: 16 · 2019: 12 · 2018: 17 · 2017: 10 · 2016: 17 · 2015: 12 · 2014: 13 · 2013: 10 · 2012: 2
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Vascular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperglycemia, endothelial dysfunction, atherosclerosis, type 1 diabetes, atherogenesis, endothelial cells, atherosclerotic plaque formation, diabetes and cardiovascular disease, metabolic syndrome, inflammation, thrombosis, vascular permeability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes. https://app.cochat.ai/papers/10.1155/2012/569654
- The paper
- Funk, S. D., Yurdagul, A., & Orr, A. W. (2012). Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes. International Journal of Vascular Medicine. https://doi.org/10.1155/2012/569654
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.